Abstract
The antithrombin generating effects of tirofiban were compared with abciximab in patients who underwent intervention and received intravenous heparin based on their weight. A standardized protocol serially measured the ACT, F1.2, and platelet receptor occupancy. Both GP IIb/IIIa agents had similar effects on reducing thrombin generation, and there were no significant differences between the groups at any measurement interval.
Original language | English (US) |
---|---|
Pages (from-to) | 1231-1233 |
Number of pages | 3 |
Journal | American Journal of Cardiology |
Volume | 87 |
Issue number | 10 |
DOIs | |
State | Published - May 15 2001 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine